 |
||||
 |
San Francisco Community EVents CROI Update P.I. Spring Brunch NASTY @
|
|
March 24, 2011 P.I. Perspective e-News Good news came with the release of early results from a studythat used the new hepatitis C drug, telaprevir, in HIV-positive people. After 12 weeks of telaprevir treatment with standard hep C drugs, nearly 70% reached undetectable HCV viral loads—a rate similar to that in mono-infected individuals. Project Inform applauds President's Project Inform praised President Obama for proposing increased funding for key care, treatment, testing, and prevention programs aligned with the goals of his National HIV/AIDS Strategy, and a significant increase in programs to fight the nation's viral hepatitis epidemic. Mark your calendars for Project Inform's On Sunday, May 22, Project Inform will mark the 30th year since the emergence of HIV/AIDS. Other news from CROI:New gene therapy shows promising results New version of tenofovir is moving well through early study Post-menopausal women may be at Prevention study increases our understanding Thinner arms and legs with thicker bellies increases risk of death Unique regimen working well in treatment experienced people Use of A1C screening may not be enough to detect diabetes in HIV-positive people Rectal use of the CAPRISA vaginal gel to prevent HIV runs into problems New publications from Project Inform |
|
 |
||||
